140 related articles for article (PubMed ID: 20646395)
1. Effects of change in rectal cancer management on outcomes in British Columbia.
Phang PT; McGahan CE; McGregor G; MacFarlane JK; Brown CJ; Raval MJ; Cheifetz R; Hay JH
Can J Surg; 2010 Aug; 53(4):225-31. PubMed ID: 20646395
[TBL] [Abstract][Full Text] [Related]
2. Results of curative surgery and postoperative chemoradiation for rectal adenocarcinoma in British Columbia, 1985 to 1994.
Ma R; Phang PT
Can J Surg; 2001 Oct; 44(5):377-82. PubMed ID: 11603752
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.
Sung SY; Jang HS; Kim SH; Jeong JU; Jeong S; Song JH; Chung MJ; Cho HM; Kim HJ; Kim JG; Lee IK; Lee JH
Ann Surg; 2019 Jan; 269(1):108-113. PubMed ID: 28742692
[TBL] [Abstract][Full Text] [Related]
5. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
7. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
8. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis.
Sung S; Kim SH; Lee JH; Nam TK; Jeong S; Jang HS; Song JH; Lee JW; Bae JM; Lee JH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):647-653. PubMed ID: 28581407
[TBL] [Abstract][Full Text] [Related]
9. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
10. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
12. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
13. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.
Gavioli M; Luppi G; Losi L; Bertolini F; Santantonio M; Falchi AM; D'Amico R; Conte PF; Natalini G
Dis Colon Rectum; 2005 Oct; 48(10):1851-7. PubMed ID: 16132481
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.
Fujita S; Yamamoto S; Akasu T; Moriya Y
Int J Colorectal Dis; 2008 Nov; 23(11):1073-9. PubMed ID: 18594841
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
17. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
[TBL] [Abstract][Full Text] [Related]
18. The effect of preoperative chemoradiotherapy on lymph node harvest after total mesorectal excision for rectal cancer.
Taflampas P; Christodoulakis M; Gourtsoyianni S; Leventi K; Melissas J; Tsiftsis DD
Dis Colon Rectum; 2009 Aug; 52(8):1470-4. PubMed ID: 19617762
[TBL] [Abstract][Full Text] [Related]
19. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.
Wibe A; Møller B; Norstein J; Carlsen E; Wiig JN; Heald RJ; Langmark F; Myrvold HE; Søreide O;
Dis Colon Rectum; 2002 Jul; 45(7):857-66. PubMed ID: 12130870
[TBL] [Abstract][Full Text] [Related]
20. Transanal Local Excision for Patients With Rectal Cancer: Can Radiation Compensate for What Is Perceived as a Nondefinitive Surgical Approach?
Rackley TP; Ma RM; Brown CJ; Hay JH
Dis Colon Rectum; 2016 Mar; 59(3):173-8. PubMed ID: 26855390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]